tykhr
sign in
free sign up
Amneal Pharmaceuticals, Inc. Class A Common Stock
Drug Manufacturers - Specialty & Generic
Healthcare
AMRX
310 M shares
NYSE US
traded
09 Apr 2025
listed
no
open
6.83
52 week high
9.25
high
7.49
52 week low
6.35
low
6.71
growth
11.23 %
previous Close
6.99
P/E ratio
market cap
3.60 B
div yield
0
usd
Sep 2024
qoq
revenue
702 M
0.10 %
net incoming
-156.00 K
-102.60 %
eps
0.00 %
0.00 %
eps surprise
23.08 %
net profit margin
-0.02 %
0.00 %
operating incoming
88.81 M
-6.98 %
net change in cash
28.72 M
1.00 %
cash on hand
74.01 M
69.08 %
cost of revenue
433 M
-4.19 %
top